Loading insider details...
Beta
Latest Form 4 (Jul 6, 2026): Exercise/Conversion of 16,000 BOLD shares, $16.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | Boundless Bio, Inc. (BOLD) | Exercise/Conversion | 16,000 | $16.5K |
| Mar 9, 2026 | Lyell Immunopharma, Inc. (LYEL) | Purchase | 488,090 | $12.50M |
| Apr 4, 2024 | Boundless Bio, Inc. (BOLD) | Conversion | 589,743 | n/a |
| Feb 12, 2024 | Sana Biotechnology, Inc. (SANA) | Purchase | 363,637 | $2.00M |
| Sep 8, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 196,003 | n/a |
| Sep 1, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 217,781 | n/a |
| Aug 26, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 217,781 | n/a |
| Aug 22, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 217,781 | n/a |
| Aug 17, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 217,781 | n/a |
| Jun 11, 2022 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 217,781 | n/a |